WOONSOCKET, R.I., 2017-Nov-10 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (Nov. 9, 2017) that the opioid overdose-reversal medication naloxone is now available without an individual prescription at the 20 CVS Pharmacy locations in Delaware, including those located inside Target stores. CVS Pharmacists will be able to dispense naloxone to patients without an…
WOONSOCKET, R.I., 2017-Nov-09 — /EPR Retail News/ — CVS Health [NYSE: CVS] today (Nov. 8, 2017) announced a collaboration with the National Consortium of State-Operated Comprehensive Rehabilitation Centers (NCSOCRC) to help Americans with disabilities find meaningful employment at CVS Pharmacy locations across the country. The announcement coincides with the opening of a mock pharmacy at…
WOONSOCKET, R.I., 2017-Jul-28 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today ( July 27, 2017) that the opioid overdose-reversal medication naloxone is now available without an individual prescription at all CVS Pharmacy locations in South Dakota. Under a collaborative practice agreement between CVS Pharmacists and a local physician, CVS pharmacies, located inside Target…